BIOX

$0.41

Post-MarketAs of Mar 17, 8:00 PM UTC

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$0.41
Potential Upside
5%
Whystock Fair Value$0.43
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorBasic Materials
IndustryAgricultural Inputs

Bioceres Crop Solutions Corp., together with its subsidiaries, develops and commercializes crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products s...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$26.28M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.46
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-18.95%
Quick Ratio
Tight liquidity. Monitor cash flow carefully against debt.
0.62

Recent News

Simply Wall St.
Dec 17, 2025

What Recent Funding Pressures Mean For Bioceres Crop Solutions Valuation Narrative

Bioceres Crop Solutions stock has seen its price target framework subtly recalibrated as analysts balance the company’s differentiated agricultural technology portfolio against rising macro and funding risks in Argentina. While the core revenue growth outlook remains intact near 8.2%, a slightly higher discount rate signals a more cautious stance on country and execution risk. This leaves fair value per share broadly steady around $2.25. Read on to see how this evolving narrative may continue...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Dec 3, 2025

Why Analysts Say Bioceres’ Story Is Shifting Amid Liquidity Fears Yet Long Term Promise

Bioceres Crop Solutions has just seen its fair value estimate cut from $3.63 to $2.25 per share, even as analysts nudge their revenue growth outlook slightly higher and trim the discount rate applied to the stock. This recalibration reflects a market narrative that is growing more cautious on near term liquidity and execution risk in Argentina, yet still credits the company with solid long term earnings potential from its next generation product pipeline. Stay tuned to learn how you can track...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Nov 19, 2025

How Recent Developments Are Rewriting the Story for Bioceres Crop Solutions

Bioceres Crop Solutions stock has come under fresh scrutiny as analysts adjust their outlook. The consensus analyst price target has dipped slightly from $3.75 to $3.63, reflecting a reassessment of both opportunities and risks facing the company. Stay tuned to discover how you can stay ahead of further narrative shifts as analysts continue to evaluate Bioceres’ prospects. Stay updated as the Fair Value for Bioceres Crop Solutions shifts by adding it to your watchlist or portfolio...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
GuruFocus.com
Nov 13, 2025

Bioceres Crop Solutions Corp (BIOX) Q1 2026 Earnings Call Highlights: Navigating Revenue ...

Despite a 17% drop in revenues, Bioceres Crop Solutions Corp (BIOX) achieved a 61% increase in adjusted EBITDA through effective cost reduction and business model transition.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Nov 13, 2025

Bioceres Crop (BIOX) Reports Q1 Loss, Lags Revenue Estimates

Bioceres Crop (BIOX) delivered earnings and revenue surprises of -200.00% and -18.37%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

BEARISH
Negative press. News cycle fixated on risk factors or misses.